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The global burden of paediatric tuberculosis (TB) has been 
underappreciated. Control programmes, focused on adult 
infectious cases, have largely based case detection and 
reporting on sputum smear results.1 However, evidence 
suggests that in developing countries, where most disease 
occurs, childhood TB constitutes a large proportion of the TB 
caseload, contributing approximately 15 - 20% of all cases. 
The burden in children and impact on child health has been 
under-recognised, partly because of difficulties in confirming 
the diagnosis. Diagnostic confirmation may be difficult because 
of many factors including nonspecific clinical signs, coexisting 
malnutrition, variable interpretation of chest radiographs, 
paucibacillary disease, difficulty in obtaining specimens for 
culture and relatively low rates of bacteriological confirmation. 
As a result diagnosis in children has relied mainly on clinical 
case definitions, tuberculin skin testing and chest radiography.2  
Diagnostic uncertainty has been compounded by the HIV 
epidemic in which chronic lung disease, anergy, coexisiting 
malnutrition and nonspecific clinical and radiological signs 
make definitive diagnosis even more challenging.
The consequences of undiagnosed or untreated paediatric 
TB are especially serious as children are more likely to develop 
miliary or severe disease. Furthermore cases of childhood TB 
frequently reflect an undiagnosed adult infectious source case; 
therefore the occurrence of TB in children frequently indicates 
failure of a TB control programme. Moreover, definitive 
diagnosis and microbiological confirmation have become 
increasingly important in the era of multidrug-resistant TB 
(MDR) and extremely extensively drug-resistant TB (XDR). 
This review considers currently available and new diagnostic 
methods for pulmonary TB (PTB). Current methods have 
relied predominantly on clinical case definitions, tuberculin 
skin testing and chest radiography. Newer methods include 
improved specimens and microbiological methods, immune 
testing, especially gamma-interferon assays, phage-based tests, 
polymerase chain reaction and antigen detection.
Clinical diagnosis
Clinical symptoms and signs in children may be nonspecific for 
TB. Although a number of scoring systems for children have 
been developed, these lack diagnostic accuracy particularly 
for young, malnourished or HIV-infected children.3 Scoring 
systems usually use a combination of clinical features (chronic 
cough, weight loss or failure to thrive, history of a close 
contact) in combination with tuberculin skin test results and/or 
chest radiology findings. A review of existing scoring systems 
found that 5 of 17 had been adapted for use in HIV-infected 
children, while only 1 had been specifically developed for use 
in such children.3 Defining symptoms more accurately may be 
useful to increase the reliability of diagnosis, as addressed in 
the accompanying article in this supplement.4
Tuberculin skin testing
Tuberculin skin testing using purified protein derivative (PPD) 
can be useful for confirming TB infection. However, this test 
is technique dependent, requires standardised application and 
interpretation, and a positive result depends on an adequate 
immune response.5 The commonest causes of false-negative 
results in South African children include severe malnutrition, 
severe TB disease and HIV infection (Table I).5 Conversely, 
false-positive results can occur as a result of non-tuberculous 
mycobacteria, BCG or improper application or interpretation 
(Table I). 
Radiological diagnosis
Chest X-ray changes are frequently nonspecific for TB. 
However, certain patterns such as miliary disease, hilar 
adenopathy with airway compression and cavitary disease are 
associated with TB pulmonary disease. An atlas of diagnostic 
radiology for childhood TB is freely available through the 
website of the International Union Against Tuberculosis and 
Lung Disease (IUATLD).6 A further difficulty is the potential 
for wide intra- and inter-observer variation in interpretation of 
chest X-ray findings, especially the presence of enlarged lymph 
nodes.7
Computed tomography (CT) of the chest is more reliable for 
detecting adenopathy and pulmonary disease but has much 
higher radiation exposure, is more expensive and requires 
specialised expertise.
Microbiological diagnosis
Microbiological confirmation of childhood TB, unlike in adults, 
has not been routinely attempted particularly in primary care. 
This is partly due to the paucibacillary nature of childhood 
TB, with most children being smear negative. Microbiological 
confirmation currently depends on obtaining an adequate 
sample for acid fast staining, culture and sensitivity.  
Diagnosis of pulmonary tuberculosis in children –   
what’s new?
Heather J Zar
School of Child and Adolescent Health, Red Cross Children’s Hospital and University 
of Cape Town
Heather J Zar, MB BCh, FAAP, PhD
Corresponding author: H J Zar (heather.zar@uct.ac.za)
Pg 983-985.indd   983 9/18/07   11:35:26 AM
October 2007, Vol. 97, No. 10  SAMJ
ORIGINAL ARTICLES
984
Samples
A number of specimens have been used for confirmation of 
PTB including gastric aspirates (GL), induced sputum (IS), 
bronchoalveolar lavage (BAL) or ear swabs (in the presence 
of a chronically discharging ear). The yield from GL has 
been consistently reported to be higher than that from BAL. 
In contrast, IS is more effective than GL, even in infants.8 
In a study of young children (median age 13 months) with 
suspected PTB, the yield from a single IS was equivalent 
to that from 3 GLs while more cases were identified with 
3 sputa compared with 3 GLs.9 In addition, almost 40% of 
children who were culture positive on sputum were also 
smear positive, enabling rapid diagnosis of PTB.8 IS has 
obvious advantages over GL as the procedure is quick, does 
not require hospitalisation of the child, is relatively easy to 
perform, safe and effective; however precautions to prevent 
nosocomial transmission must be taken.8 Wider use of IS as a 
diagnostic procedure in children is warranted, especially in the 
era of MDR and XDR TB when bacteriological confirmation is 
increasingly important.
Fine-needle aspiration of a superficial lymph node (in 
lymphadenitis), bone-marrow aspiration (in miliary disease) 
and tissue biopsy of lung (especially in chronic lung disease 
where other investigations have not yielded another 
organism or cause) may be useful for detecting Mycobacterium 
tuberculosis. In addition, the string test, in which gastric 
contents adherent to a gelatine capsule (which is swallowed, 
taped in situ and then removed after a few hours) are obtained, 
has been reported to be well tolerated in older children. 
Culture methods
Lowenstein-Jensen medium has usually been used for culture 
of M. tuberculosis; results take approximately 6 weeks. More 
recently, liquid culture medium (MGIT), in which an indicator 
dye changes colour with growth, provided culture results more 
quickly, within 2 - 4 weeks. However, susceptibility testing 
required a further 3 weeks. New culture methods include 
the use of TK medium, which changes colour with growth, 
allowing for culture results within 2 weeks. This is a promising, 
inexpensive but understudied method.
Recently microscopic observation drug susceptibility 
(MODS) has been reported to be a sensitive and rapid culture 
method with results in 7 days.10 MODS uses an inverted light 
microscope to detect mycobacterial growth in liquid medium. 
Specimens are inoculated onto a microtitre plate with or 
without antibiotics and examined daily for growth. A study 
of over 3 000 specimens comparing MODS, liquid medium 
and Lowenstein-Jensen found a similar culture positive rate 
(11%) for all.10 However, MODS provided both culture and 
susceptibility results within 7 days, which was significantly 
quicker than the others (13 and 22 days for liquid medium and 
26 and 68 days for Lowenstein-Jensen).10 This technique is very 
promising but is labour intensive. 
Interferon assays
These in vitro tests measure gamma-interferon production 
by T cells. The principle of these assays is that sensitised T 
cells produce interferon when they encounter mycobacterial 
antigens. Initial assays used purified protein derivative 
(PPD), which contains a mixture of antigens shared by 
many mycobacterial species. However, new assays use M. 
tuberculosis-specific antigens such as ESAT-6 and CFP-10. Two 
commercial assays are available and utilise ELISA or Elispot 
technology. Quantiferon-TB measures interferon production 
in whole blood; results are expressed as IFN pdxn (pg/ml). 
T SPOT-TB uses peripheral mononuclear cells to detect the 
number of T cells producing interferon; results are expressed as 
the number of spot-forming cells. 
Generally interferon assays have been reported to have 
higher sensitivity and specificity compared with tuberculin 
skin testing.10 However, there is relatively little information 
in young children and HIV-infected children. One study of 
children with suspected TB in rural KwaZulu-Natal reported 
that the sensitivity of the Elispot interferon assays (83%) was 
significantly higher than PPD testing (63%).11 This occurred in 
the subgroup of young children under 3 years (85% v. 51%), 
HIV-infected children (73% v. 36%) and malnourished children 
(78% v. 44%).11 Combining ELISPOT and PPD improved the 
diagnostic sensitivity to 91%, so additional accuracy was 
achieved by using both.
Table I.  Causes of false-positive or false-negative tuberculin skin tests (TSTs) in children5 
False-negative TST      False-positive TST
Improper placing/interpretation    Improper interpretation
HIV infection      BCG vaccination
Malnutrition or low-protein states    Non-tuberculous mycobacteria 
Severe TB 
Improper storage of tuberculin
Viral infections
Bacterial infections
Live viral vaccines (within 6 weeks)
Immunodeficiencies (other than HIV)
Neonates
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Concerns about interferon assays include the inability to 
distinguish latent from active disease, the relative lack of 
studies in children, their applicability in high-incidence HIV 
and TB settings and discordance with PPD results. Use of 
assays is also limited by their cost and the need for laboratory 
infrastructure. Nevertheless, these assays are promising, 
more sensitive than tuberculin skin testing, and an important 
addition to improving diagnostic accuracy for M. tuberculosis. 
Phage-based tests
These use bacteriophages to infect M. tuberculosis and can also 
detect resistance. They provide rapid results within 2 - 3 days 
but are less sensitive than culture.12 Phage-based assays have 
not been validated in children and require laboratory expertise.
Polymerase chain reaction (PCR)
PCR for M. tuberculosis has produced variable and 
disappointing results to date. Studies report poor sensitivity 
in paucibacillary disease and in extrapulmonary TB but good 
specificity. In smear-negative disease sensitivity is around 
50 - 60% but  specificity approaches 99%.13 In general PCR is 
less sensitive than culture and is limited by cost and need for 
laboratory expertise and infrastructure.
Antigen-based tests
These detect TB-specific antigens such as lipoarabinomannan 
(LAM). The LAM assay in urine or sputum using ELISA test 
has been reported to have a sensitivity of 80%.14 However, there 
are limited data on their accuracy and they have not been well 
validated in children.
Antibody-based tests
The available serological assays are highly variable in their 
sensitivity and specificity. Serological assays are limited as 
antibody responses are variable, they do not distinguish latent 
from active disease and their reliability may be influenced by 
other factors like HIV, BCG and non-tuberculous mycobacteria 
(NTM).15 In the future, a useful serological test will need to 
assay a number of antibodies, not a single antibody.
Conclusion
Diagnosis of TB in children remains challenging, especially 
in the era of HIV. Diagnosis cannot rely on a single factor, but 
on a constellation of findings and tests. Careful and optimal 
technique should be used for existing tests. Improved immune 
diagnostic tests and microbiological methods are valuable 
additions in diagnosis. Greater efforts at microbiological 
confirmation should to be made in children, including in 
primary care settings. Simpler, cost-effective, faster and more 
accurate diagnostic methods for TB are urgently needed for 
children in developing countries.
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